导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.13% | 639/1050 |
| 近一周 | -3.61% | 993/1104 |
| 近一月 | -1.26% | 266/1103 |
| 近一季 | -19.28% | 961/1092 |
| 近半年 | -17.00% | 949/1070 |
| 近一年 | 18.71% | 271/1018 |
| 近两年 | 87.11% | 259/926 |
| 近三年 | 62.81% | 200/834 |
| 成立以来 | 197.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
9.77% 47/1070 |
13.89% 473/1101 |
- - |
- - |
| 2025 | 74.52% 51/1065 |
4.08% 472/1014 |
11.05% 81/1038 |
31.06% 341/1050 |
15.20% 22/1065 |
| 2024 | -4.97% 707/1011 |
-0.56% 345/960 |
-1.51% 406/983 |
4.69% 892/991 |
-7.32% 791/1011 |
| 2023 | -15.03% 523/952 |
-5.21% 797/880 |
-8.99% 737/895 |
-2.85% 197/915 |
1.39% 81/952 |
| 2022 | -18.79% 291/867 |
-17.68% 405/773 |
16.96% 71/806 |
-12.79% 446/845 |
-3.27% 590/867 |
| 2021 | 29.28% 76/740 |
-11.97% 524/580 |
32.81% 43/659 |
9.61% 69/704 |
0.89% 397/740 |
| 2020 | 81.93% 86/554 |
-1.02% 186/419 |
33.52% 86/466 |
15.33% 140/517 |
19.36% 131/554 |
| 2019 | 36.99% 244/410 |
22.34% 850/1146 |
-2.12% 528/1228 |
3.04% 254/390 |
11.02% 134/410 |
| 2018 | -33.04% 254/349 |
- - |
-4.29% 169/990 |
-15.50% 950/1000 |
-11.20% 420/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 申万菱信行业轮动股票A VS. 东吴新产业精选股票A(580008) |